M. YÜKSEL TEK Et Al. , "The extracellular amyloid beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer s disease like cellular model," 41. FEBS kongresi , 2017
YÜKSEL TEK, M. Et Al. 2017. The extracellular amyloid beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer s disease like cellular model. 41. FEBS kongresi .
YÜKSEL TEK, M., BİBEROĞLU, K., ÖNDER, S., AKBULUT, K. G., & TACAL, Ö., (2017). The extracellular amyloid beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer s disease like cellular model . 41. FEBS kongresi
YÜKSEL TEK, MELİKE Et Al. "The extracellular amyloid beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer s disease like cellular model," 41. FEBS kongresi, 2017
YÜKSEL TEK, MELİKE Y. Et Al. "The extracellular amyloid beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer s disease like cellular model." 41. FEBS kongresi , 2017
YÜKSEL TEK, M. Et Al. (2017) . "The extracellular amyloid beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer s disease like cellular model." 41. FEBS kongresi .
@conferencepaper{conferencepaper, author={MELİKE YÜKSEL TEK Et Al. }, title={The extracellular amyloid beta levels are reduced by the cholinesterase inhibitor toluidine blue O in an Alzheimer s disease like cellular model}, congress name={41. FEBS kongresi}, city={}, country={}, year={2017}}